Cindy Fevre
Chief Tech/Sci/R&D Officer chez PHAXIAM THERAPEUTICS S.A.
Profil
Cindy Fevre is currently the Chief Scientific Officer at PHAXIAM Therapeutics SA since 2023.
Previously, she worked as a Research Director at Pherecydes Pharma SA. She holds a doctorate degree from the Pasteur Institute.
Postes actifs de Cindy Fevre
| Sociétés | Poste | Début |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 23/06/2023 |
Anciens postes connus de Cindy Fevre
| Sociétés | Poste | Fin |
|---|---|---|
| PHERECYDES PHARMA | Chief Tech/Sci/R&D Officer | - |
Formation de Cindy Fevre
| Pasteur Institute | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
